drugset / Trial / NCT00984503

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

NCT00984503

Phase 2 Completed 102 enrolled Renovo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the accelerated-healing potential of injection or injection plus topical application of Juvista to minor split skin grafts (SSG).

Timeline

Start
2003-10
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 50 ng Other
Subject Avotermin Protein / enzyme biologic 100 ng Other

Indications

No indication recorded.